On Thursday (Sep, 14, 2023), Anavex Life Sciences released additional data from their phase 2b/3 Alzheimer's Disease trial. The company stated that (after a new post hoc analysis), the trial showed ...
Beam Therapeutics Inc. (BEAM) is gearing up to release four abstracts at the upcoming American Society of Hematology [ASH] annual meeting in 2024. The thing is that the company notes in its earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results